ADULT;
ARTICLE;
CONTROLLED STUDY;
DRUG COST;
FEMALE;
HEALTH CARE COST;
HEALTH CARE UTILIZATION;
HOSPITAL PATIENT;
HOSPITALIZATION;
HUMAN;
LENGTH OF STAY;
MAINTENANCE THERAPY;
MAJOR CLINICAL STUDY;
MALE;
MEDICAL RECORD REVIEW;
OUTCOME ASSESSMENT;
OUTPATIENT CARE;
PATIENT MONITORING;
PRIORITY JOURNAL;
TREATMENT DURATION;
TREATMENT RESPONSE;
ULCERATIVE COLITIS;
World Gastroenterology Organization Practice Guidelines for the diagnosis and management of IBD in 2010
Bernstein CN, Fried M, Krabshuis JH, et al. World Gastroenterology Organization Practice Guidelines for the diagnosis and management of IBD in 2010. Inflamm Bowel Dis. 2010;16(1):112-124.
Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences
Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology. 2004;126(6):1504-1517.
Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults
Kappelman MD, Rifas-Shiman SL, Porter CQ, et al. Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults. Gastroenterology. 2008;135(6):1907-1913.
Practice Parameters Committee of the American College of Gastroenterology. Ulcerative colitis practice guidelines in adults: American College of Gastroenterology, Practice Parameters Committee
Kornbluth A, Sachar DB, Practice Parameters Committee of the American College of Gastroenterology. Ulcerative colitis practice guidelines in adults: American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol. 2010;105(3):501-523.
Infliximab for induction and maintenance therapy for ulcerative colitis [published correction appears in N Engl J Med. 2006;354(20):2200]
Rutgeerts P, Sandborn WJ, Feagan BG, et al. Infliximab for induction and maintenance therapy for ulcerative colitis [published correction appears in N Engl J Med. 2006;354(20):2200]. N Engl J Med. 2005;353(23):2462-2476.
(2005)N Engl J Med, vol.353, Issue.23, pp. 2462-2476
Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximab
Sandborn WJ, Rutgeerts P, Feagan BG, et al. Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximab. Gastroenterology. 2009;137(4):1250-1260.
Medication non-adherence is associated with increased medical health care costs
DOI 10.1007/s10620-007-9968-0
Kane S, Shaya F. Medication non-adherence is associated with increased medical healthcare costs. Dig Dis Sci. 2008;53(4):1020-1024. (Pubitemid 351379831)
American gastroenterological association consensus development conference on the use of biologics in the treatment of inflammatory bowel disease, June 21-23, 2006
Clark M, Colombel J-F, Feagan BC, et al. American gastroenterological association consensus development conference on the use of biologics in the treatment of inflammatory bowel disease, June 21-23, 2006. Gastroenterology. 2007;133(1):312-339.
